ENDRA Life Sciences Inc. (NDRA)
NASDAQ: NDRA · Real-Time Price · USD
6.70
+0.13 (1.98%)
At close: Nov 14, 2025, 4:00 PM EST
6.29
-0.41 (-6.12%)
After-hours: Nov 14, 2025, 7:46 PM EST
ENDRA Life Sciences Market Cap
ENDRA Life Sciences has a market cap or net worth of $5.04 million as of November 14, 2025. Its market cap has decreased by -4.01% in one year.
Market Cap
5.04M
Enterprise Value
3.79M
1-Year Change
-4.01%
Ranking
Category
Stock Price
$6.70
Market Cap Chart
Since June 30, 2017, ENDRA Life Sciences's market cap has decreased from $15.15M to $5.04M, a decrease of -66.71%. That is a compound annual growth rate of -12.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 5.04M | 50.06% |
| Dec 31, 2024 | 3.36M | -81.25% |
| Dec 29, 2023 | 17.92M | 39.49% |
| Dec 30, 2022 | 12.85M | -55.92% |
| Dec 31, 2021 | 29.15M | 15.68% |
| Dec 31, 2020 | 25.20M | 100.27% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 915.86B |
| Johnson & Johnson | 470.41B |
| AbbVie | 410.55B |
| UnitedHealth Group | 301.21B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 230.65B |
| Abbott Laboratories | 224.77B |